This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Laboratories Limited. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Gordan Ian Gregory: Innovator in Antibiotic Compounds
Introduction
Gordan Ian Gregory is a notable inventor based in Chalfont St. Peter, GB. He has made significant contributions to the field of antibiotic compounds, showcasing his expertise through his innovative patent.
Latest Patents
Gordan Ian Gregory holds a patent for a novel antibiotic compound characterized as 7.beta.-[2-Etherified oximino-2-(phenyl or -acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof. This invention provides compounds that possess high antibacterial activity against a range of gram-positive and gram-negative organisms. The compounds are particularly stable against .beta.-lactamases produced by various gram-negative organisms. The patent emphasizes the administration of these compounds, highlighting their potential in medical applications.
Career Highlights
Gordan Ian Gregory is associated with Glaxo Laboratories Limited, where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing antibiotic research and development.
Collaborations
Gordan has collaborated with notable coworkers, including Martin Christopher Cook and Janice Bradshaw. Their combined efforts have furthered research in the field of antibiotics and enhanced the impact of their innovations.
Conclusion
Gordan Ian Gregory's contributions to antibiotic compounds reflect his dedication to innovation in the pharmaceutical industry. His patent demonstrates the potential for significant advancements in combating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile